A Prospective, Open-label, Nonrandomized Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain

Trial Profile

A Prospective, Open-label, Nonrandomized Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs Ketorolac (Primary)
  • Indications Acute pain
  • Focus Therapeutic Use
  • Acronyms Sprix
  • Most Recent Events

    • 16 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 29 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
    • 01 Feb 2016 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top